Stockscreener 앱 받기
10.88
1.18%
-0.13
전일 마감가:
$11.01
열려 있는:
$11
하루 거래량:
3,891
Relative Volume:
0.02
시가총액:
$237.44M
수익:
-
순이익/손실:
$-35.46M
주가수익비율:
-25.79
EPS:
-0.4218
순현금흐름:
$-34.00M
1주 성능:
-2.94%
1개월 성능:
-4.14%
6개월 성능:
+165.37%
1년 성능:
-34.65%
1일 변동 폭
$10.75
$11.00
1주일 범위
$10.36
$11.23
52주 변동 폭
$3.35
$20.24
Contineum Therapeutics Inc Stock (CTNM) Company Profile
명칭
Contineum Therapeutics Inc
전화
(858) 333-5280
주소
3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO
CTNM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CTNM
Contineum Therapeutics Inc
|
10.98 | 321.30M | 0 | -35.46M | -34.00M | -0.4218 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.74 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
640.57 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
444.54 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.40 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.00 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Contineum Therapeutics Inc Stock (CTNM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-25 | 개시 | Leerink Partners | Outperform |
| 2025-06-20 | 개시 | William Blair | Outperform |
| 2024-10-22 | 개시 | Robert W. Baird | Outperform |
| 2024-04-30 | 개시 | Morgan Stanley | Overweight |
| 2024-04-30 | 개시 | RBC Capital Mkts | Outperform |
| 2024-04-30 | 개시 | Stifel | Buy |
모두보기
Contineum Therapeutics Inc 주식(CTNM)의 최신 뉴스
Real time social sentiment graph for Contineum Therapeutics Inc.July 2025 Momentum & Daily Chart Pattern Signals - newser.com
Live market analysis of Contineum Therapeutics Inc.July 2025 Opening Moves & Community Consensus Stock Picks - newser.com
Why retail investors pile into Contineum Therapeutics Inc. stockJuly 2025 Patterns & Fast Moving Trade Plans - newser.com
How Contineum Therapeutics Inc. stock compares to growth peersEntry Point & Scalable Portfolio Growth Ideas - newser.com
How Contineum Therapeutics Inc. stock reacts to inflationary pressuresCEO Change & Fast Momentum Stock Entry Tips - newser.com
Volatility clustering patterns for Contineum Therapeutics Inc.July 2025 Breakouts & AI Optimized Trade Strategies - newser.com
Can Contineum Therapeutics Inc. stock outperform in 2025 bull market2025 Valuation Update & Fast Exit/Entry Strategy Plans - newser.com
Risk adjusted return profile for Contineum Therapeutics Inc. analyzedJuly 2025 Summary & Stock Timing and Entry Methods - newser.com
What momentum shifts mean for Contineum Therapeutics Inc.2025 Market Sentiment & Free Safe Capital Growth Stock Tips - newser.com
Will Contineum Therapeutics Inc. stock split attract more investors2025 Major Catalysts & Consistent Profit Alerts - newser.com
Contineum Therapeutics Inc. stock momentum explainedJuly 2025 Short Interest & Smart Money Movement Alerts - newser.com
Using Ichimoku Cloud for Contineum Therapeutics Inc. technicalsJuly 2025 Highlights & High Accuracy Investment Entry Signals - newser.com
Contineum Therapeutics (NASDAQ:CTNM) Issues Quarterly Earnings Results - MarketBeat
Using data models to predict Contineum Therapeutics Inc. stock movementPortfolio Gains Report & Daily Technical Stock Forecast Reports - newser.com
Buy Rating for Contineum Therapeutics: Promising Advancements in Clinical Pipeline and Strategic Opportunities - TipRanks
Is Contineum Therapeutics Inc. building a consolidation baseWeekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
What makes RF Acquisition Corp II stock price move sharply - newser.com
Building trade automation scripts for Contineum Therapeutics Inc.2025 Momentum Check & Reliable Entry Point Trade Alerts - newser.com
Is it time to cut losses on Contineum Therapeutics Inc.2025 Sector Review & Real-Time Market Sentiment Reports - newser.com
Contineum Therapeutics Reports Increased R&D Investment Amid Losses - TipRanks
Is Contineum Therapeutics Inc. stock attractive for growth ETFsJuly 2025 Earnings & Long Hold Capital Preservation Tips - newser.com
Visual trend scoring systems applied to Contineum Therapeutics Inc.July 2025 Patterns & Daily Profit Maximizing Tips - newser.com
[10-Q] Contineum Therapeutics, Inc. Quarterly Earnings Report | CTNM SEC FilingForm 10-Q - Stock Titan
CTNM 8-K: Q3 2025 results press release furnished (Exhibit 99.1) - Stock Titan
Contineum Therapeutics Reports Third-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones - Business Wire
Contineum Therapeutics (CTNM) Expected to Announce Earnings on Wednesday - MarketBeat
Contineum Therapeutics Inc (CTNM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.03%
0.32%
자본화:
|
볼륨(24시간):